Drug Trial News

RSS
Should pregnant women be included clinical trials?

Should pregnant women be included clinical trials?

First Phase II study of immunotherapy combined with curative radiotherapy for unresectable locally advanced NSCLC

First Phase II study of immunotherapy combined with curative radiotherapy for unresectable locally advanced NSCLC

Consolidation PD-(L)1 inhibition following concurrent chemoradiation for unresectable stage III NSCLC improves survival

Consolidation PD-(L)1 inhibition following concurrent chemoradiation for unresectable stage III NSCLC improves survival

Neoadjuvant chemoimmunotherapy highly effective in patients with resectable stage IIIA NSCLC

Neoadjuvant chemoimmunotherapy highly effective in patients with resectable stage IIIA NSCLC

Trial evaluates sugemalimab as a consolidation treatment in patients with unresectable stage III NSCLC

Trial evaluates sugemalimab as a consolidation treatment in patients with unresectable stage III NSCLC

Monoclonal antibody protects U.S. adults from malaria, Phase 1 clinical trial shows

Monoclonal antibody protects U.S. adults from malaria, Phase 1 clinical trial shows

TransCode and MD Anderson scientists collaborate to validate therapeutic and diagnostic candidates

TransCode and MD Anderson scientists collaborate to validate therapeutic and diagnostic candidates

New trial offers double the traditional course of antibiotics for patients with life threatening infections

New trial offers double the traditional course of antibiotics for patients with life threatening infections

Is cannabidiol effective against COVID-19?

Is cannabidiol effective against COVID-19?

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

Oncology trial data not available for independent scrutiny, study finds

Oncology trial data not available for independent scrutiny, study finds

FDA clears IND application for MD Anderson-sponsored Phase I clinical study of OBX-115 therapy

FDA clears IND application for MD Anderson-sponsored Phase I clinical study of OBX-115 therapy

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

Nanotherapeutic compound may help treat inflammation, brain injury in patients with severe COVID-19

Nanotherapeutic compound may help treat inflammation, brain injury in patients with severe COVID-19

The potential of circular RNA COVID-19 vaccines

The potential of circular RNA COVID-19 vaccines

Lumasiran shows efficacy and acceptable safety in patients with PH1 and advanced kidney disease

Lumasiran shows efficacy and acceptable safety in patients with PH1 and advanced kidney disease

Phase I clinical trial of new blocking antibody therapy shows promising results for the treatment of advanced medulloblastoma

Phase I clinical trial of new blocking antibody therapy shows promising results for the treatment of advanced medulloblastoma

University of Oxford begins recruiting for Phase I trial of new TB vaccine

University of Oxford begins recruiting for Phase I trial of new TB vaccine

NIH launches clinical trial evaluating an experimental vaccine to prevent Nipah virus infection

NIH launches clinical trial evaluating an experimental vaccine to prevent Nipah virus infection

Monoclonal antibody treatment taken by hospitalized COVID-19 patients reduces mortality

Monoclonal antibody treatment taken by hospitalized COVID-19 patients reduces mortality